Surgico-pathological stage I primary fallopian tube adenocarcinoma

International Journal of Gynecology and Obstetrics

Volumn 63, Issue 1, 1998, Pages 73-74

  Wang, P H ^a   Yuan, C C ^a   Chao, H T ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Primary fallopian tube cancer; Prognostic factors

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADENOCARCINOMA; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; PRIORITY JOURNAL; UTERINE TUBE;

EID: 0032192219     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(98)00098-8     Document Type: Article

References (4)

1. DiSaia PJ, Creasman WT. Carcinoma of the fallopian tube. In: DiSaia PJ, Creasman WT, editors. Clinical Gynecologic Oncology. 5th. St Louis: Mosby-Year Book, 1997:375-381.
2. Rosen AC, Sevelda P, Klein Met al. A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. Br J Cancer. 69:1994;577-579.
3. Barakat RR, Rubin SC, Saigo PEet al. Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube. Gynecol Oncol. 42:1991;156-160.
4. Cormio G, Maneo A, Gabriele A, Zanetta G, Losa G, Lissoni A Treatment of fallopian tube carcinoma with cyclophosphamide, adriamycin, and cisplatin. Am J Clin Oncol. 20:1997;143-145.